NCT02830191View on ClinicalTrials.gov

Therapeutic Drug Monitoring (TDM) of Cyclosporine in Kidney Transplant Patients by Dried Blood Spot Assay. Interest and Feasibility.

CompletedOBSERVATIONAL
Enrollment

22

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions
Kidney Transplantation
All Listed Sponsors
lead

University Hospital, Caen

OTHER

NCT02830191 - Therapeutic Drug Monitoring (TDM) of Cyclosporine in Kidney Transplant Patients by Dried Blood Spot Assay. Interest and Feasibility. | Biotech Hunter | Biotech Hunter